NCT06060301View on ClinicalTrials.gov

Topical Sulfasalazine and Oral Lichen Planus

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

September 1, 2024

Study Completion Date

October 20, 2024

Conditions
Oral Lichen PlanusTopical SulfasalazineCorticosteroids
Interventions
DRUG

sulfasalazine 500 MG

The patients will use topical corticosteroids in addition to topical sulfasalazine 4 times per day.

DRUG

corticosteroids

The patients will use topical corticosteroids 4 times per day.

Trial Locations (1)

115

Faculty of Dentistry, Cairo University, Cairo

All Listed Sponsors
lead

Cairo University

OTHER